Pharmaceutical Insights
Navigate pharmaceutical trends with our insights on targets, institutional pipelines, clinical advances, and new drugs.
blog-list-cover
Recent blog posts
Ontunisertib in Crohn Disease: NCT07683325 Clinical Landscape Report 2026
9 min read
Ontunisertib in Crohn Disease: NCT07683325 Clinical Landscape Report 2026
18 September 2026
NCT07683325 clinical landscape for Crohn Disease: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
Read →
Prilocaine Hydrochloride in Pain: NCT07683182 Clinical Landscape Report 2026
9 min read
Prilocaine Hydrochloride in Pain: NCT07683182 Clinical Landscape Report 2026
18 September 2026
NCT07683182 clinical landscape for Pain: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
Read →
Ipilimumab in Locally Advanced Pancreatic Adenocarcinoma: NCT07683221 Clinical Landscape Report 2026
9 min read
Ipilimumab in Locally Advanced Pancreatic Adenocarcinoma: NCT07683221 Clinical Landscape Report 2026
18 September 2026
NCT07683221 clinical landscape for Locally Advanced Pancreatic Adenocarcinoma: endpoints, sponsor, phase, geography, readouts, asset context and development…
Read →
IL-12 (SYTE) in Crohn Disease: NCT07686757 Clinical Landscape Report 2026
9 min read
IL-12 (SYTE) in Crohn Disease: NCT07686757 Clinical Landscape Report 2026
18 September 2026
NCT07686757 clinical landscape for Crohn Disease: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
Read →
Acetaminophen/Ibuprofen in Pain: NCT07687394 Clinical Landscape Report 2026
9 min read
Acetaminophen/Ibuprofen in Pain: NCT07687394 Clinical Landscape Report 2026
18 September 2026
NCT07687394 clinical landscape for Pain: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
Read →
Erythropoietin(Xiamen Amoytop Biotech Co. Ltd.) in Urologic Diseases: ISRCTN16119881 Clinical Landscape Report 2026
9 min read
Erythropoietin(Xiamen Amoytop Biotech Co. Ltd.) in Urologic Diseases: ISRCTN16119881 Clinical Landscape Report 2026
18 September 2026
ISRCTN16119881 clinical landscape for Urologic Diseases: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
Read →
EC-5026 in Chronic Kidney Diseases: NCT07694544 Clinical Landscape Report 2026
9 min read
EC-5026 in Chronic Kidney Diseases: NCT07694544 Clinical Landscape Report 2026
18 September 2026
NCT07694544 clinical landscape for Chronic Kidney Diseases: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
Read →
INT-210 in Colitis, Ulcerative: NCT07692165 Clinical Landscape Report 2026
9 min read
INT-210 in Colitis, Ulcerative: NCT07692165 Clinical Landscape Report 2026
18 September 2026
NCT07692165 clinical landscape for Colitis, Ulcerative: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
Read →
Albumin-Bound Paclitaxel in Pancreatic Ductal Adenocarcinoma: NCT07699757 Clinical Landscape Report 2026
9 min read
Albumin-Bound Paclitaxel in Pancreatic Ductal Adenocarcinoma: NCT07699757 Clinical Landscape Report 2026
18 September 2026
NCT07699757 clinical landscape for Pancreatic Ductal Adenocarcinoma: endpoints, sponsor, phase, geography, readouts, asset context and development white spac…
Read →
Secukinumab in Diabetes Mellitus, Type 2: NCT07704190 Clinical Landscape Report 2026
9 min read
Secukinumab in Diabetes Mellitus, Type 2: NCT07704190 Clinical Landscape Report 2026
18 September 2026
NCT07704190 clinical landscape for Diabetes Mellitus, Type 2: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
Read →
JS-212 in Advanced Lung Non-Small Cell Carcinoma: NCT07714304 Clinical Landscape Report 2026
9 min read
JS-212 in Advanced Lung Non-Small Cell Carcinoma: NCT07714304 Clinical Landscape Report 2026
18 September 2026
NCT07714304 clinical landscape for Advanced Lung Non-Small Cell Carcinoma: endpoints, sponsor, phase, geography, readouts, asset context and development whit…
Read →
Ferrous Sulfate/Ascorbic Acid in Anemia in chronic kidney disease: TCTR20260721005 Clinical Landscape Report 2026
9 min read
Ferrous Sulfate/Ascorbic Acid in Anemia in chronic kidney disease: TCTR20260721005 Clinical Landscape Report 2026
18 September 2026
TCTR20260721005 clinical landscape for Anemia in chronic kidney disease: endpoints, sponsor, phase, geography, readouts, asset context and development white…
Read →